SKYLER ELLSWORTH: Open Payments
NPI 1932784386 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 33 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $266 · 2025 $822
Food & beverage: $657Education: $165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $182 |
| Janssen Biotech, Inc. | 3 | $109 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Galderma Laboratories, L.P. | 2 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| GENZYME CORPORATION | 3 | $52 |
| Incyte Corporation | 2 | $34 |
| UCB, Inc. | 2 | $33 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, NEMLUVIO, COSENTYX, RINVOQ, ILUMYA, OPZELURA.
Industry payments across ID — which companies pay providers there.
